ConductScience.org, home

Trial · NCT07880847

Registered outcomes22

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryEdmonton Obesity Staging System (EOSS)Baseline (T0) and post training (12-weeks, T1)It is a clinical system that classifies obesity based on its impact on physical, mental, and functional health. It includes five stages (0-4) that reflect the severity of obesity-related conditions.
PrimaryMoynihan's Food Knowledge QuestionnaireBaseline (T0) and post training (12-weeks, T1)It is a tool that measures how much people know about the principles of healthy nutrition, the nutritional composition of various types of foods, their macronutrients, and fiber.
PrimaryHandgrip TestBaseline (T0) and post training (12-weeks, T1)
It measures the maximum isometric strength of the upper limb muscles, particularly those of the forearm and hand. The participant is asked to hold their arm in a neutral position, with the forearm flexed at a 90° angle in the mid-range position, and to gradually squeeze a dynamometer with as much force as possible. Force is measured in kilograms.
PrimarySix-minute Walk TestBaseline (T0) and post training (12-weeks, T1)It is a functional test that measures the maximum distance a person can cover in six minutes by walking as fast as possible along a flat path. The total distance is measured in meters.
PrimaryBorg CR10 ScaleBaseline (T0) and post training (12-weeks, T1)
It is a scale used to measure the subjective perception of fatigue, and pain during physical or work-related activities. The score ranges from 0 (complete rest) to 10 (the greatest effort you have ever experienced in your life).
PrimaryInstrumental Activity of Daily Living (IADL)Baseline (T0) and post training (12-weeks, T1)
It is a scale used to assess a patient's level of independence in basic and instrumental activities of daily living. The maximum score varies by gender: 0-8 for women and 0-5 for men. The higher the score, the greater the level of independence in basic daily instrumental activities.
PrimaryWOMAC Osteoarthritis IndexBaseline (T0) and post training (12-weeks, T1)
It is a self-report instrument designed to detect changes in symptoms and limitations in daily activities resulting from osteoarthritis. The scale consists of 24 items, organized into three subscales: pain (5 items), stiffness (2 items), and function (17 items). Each item is rated on a Likert scale from 0 to 4, where 0 indicates the absence of symptoms and 4 represents symptoms or difficulties of high intensity.
PrimaryBasic Activity of Daily Living (BADL)Baseline (T0) and post training (12-weeks, T1)It is a scale that assesses a patient's independence in performing basic activities of daily living. Total scores range from 0 to 6.
PrimaryVisual Analogue Scale (VAS)Baseline (T0) and post training (12-weeks, T1)
It is used in this protocol in two different ways, with the aim of measuring subjective aspects reported by the patient. The first application, the Pain VAS, provides a visual representation of the intensity of subjective pain. The patient must mark the line to indicate the perceived pain on a 10-cm line, with one end indicating no pain (corresponding to 0) and the other end indicating the worst pain imaginable (corresponding to 10). The second application, the Functional VAS, follows the same structure but is designed to assess the patient's subjective perception of their functional ability. The Functional VAS is also represented by a 10-cm line, where one end (0) indicates "no difficulty / maximum functionality," while the other end (10) indicates "maximum difficulty / lack of functionality."
PrimaryEuroQoL 5D e EuroQoL VASBaseline (T0) and post training (12-weeks, T1)
These are two scales that examine quality of life. The EuroQoL 5d is a questionnaire consisting of 5 items that can be answered using a 3-point Likert scale ranging from 1 (no problem) to 3 (serious problem). The EuroQoL VAS is a visual analog scale represented by a graduated thermometer, where the temperature corresponds to the perceived quality of life. The scale ranges from 0 (worst possible health condition) to 100 (best possible health condition), and the respondent is asked to estimate their current level of health by marking the temperature that best represents it.
PrimaryMindful Attention Awareness Scale (MAAS)Baseline (T0) and post training (12-weeks, T1)It measures dispositional mindfulness, defined as a habitual tendency to maintain open and conscious attention to the experience of the present moment, free from automatic responses and distractions.
PrimaryGeneralized Anxiety Disorder (GAD-7)Baseline (T0) and post training (12-weeks, T1)
It is a self-administered questionnaire designed to identify and monitor anxiety symptoms experienced over the past two weeks. Total scores range from 0 to 21. Higher scores indicate more severe anxiety.
PrimaryPatient Health Questionnaire 9 (PHQ-9)Baseline (T0) and post training (12-weeks, T1)It is a tool used to assess the severity of depressive symptoms over the past two weeks. Total scores range form 0 to 27. Higher scores indicate more severe depression.
PrimaryThree-Factor Eatin Questionnaire, 18 item (TFEQ-R18)Baseline (T0) and post training (12-weeks, T1)
It examines three key dimensions of eating behavior: cognitive restriction (the tendency to voluntarily control food intake to manage weight), uncontrolled eating (the tendency to lose control and overeat in response to internal or environmental cues), and emotional eating (eating in response to negative emotional states). The survey is self-administered, with responses on a Likert scale.
PrimaryAntecedents and Self-efficacy on Adherence (ASonA)Baseline (T0) and post training (12-weeks, T1)
It is designed to estimate the probability of adherence to a given protocol by identifying both behavioral and cognitive antecedents and task-specific self-efficacy. The total score ranges from 0 to 80. Higher scores indicate greater adherence.
PrimaryClinical Impairment Asessment (CIA)Baseline (T0) and post training (12-weeks, T1)
It quantifies the degree of psychosocial impairment attributable to the thoughts and behaviors typical of eating disorders, as observed over the past four weeks. The total score ranges from 0 to 48. A higher score indicates a more severe impairment.
PrimaryAge of participantsBaseline (T0)mean age of participants
PrimarySex distribution of participantsBaseline (T0)Number and percentage of patients by sex
PrimaryEducation levelBaseline (T0)years of formal education completed by patients
PrimaryClinical and lifestyle characteristicsBaseline (T0)Number and percentage of participants presenting comorbidities, regular physical activity, tobacco use, alcohol consumption, current medical therapy, etc.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07880847/registered